Andrew.A couple of brokers came out this week and advised their clients to take some profit off the top but also reminded them that the acr story is a very good story.I think that selling is now out the way. I think some of the overseas investors who attended the recent biotech conference in melbourne have also been buying.The fda approval for axiron cannot be far away if the fda sticks to their normal schedule.We may not have much longer to wait.
Add to My Watchlist
What is My Watchlist?
